Literature DB >> 8551406

Treatment of hemangiomas of infants with high doses of prednisone.

N Sadan1, B Wolach.   

Abstract

OBJECTIVE: We reviewed our experience with the use of oral corticosteroid therapy in treating hemangiomas of infants to determine the optimal effective dose. STUDY
DESIGN: During a 24-year period, 60 infants with hemangiomas were treated with an initial dose of either 3 or 5 mg/kg per day of orally administered prednisone for a period ranging from 6 to 12 weeks. Involution of the hemangioma and re-growth. were monitored.
RESULTS: Overall, excellent and rapid results were achieved in 68% of infants and good results occurred in 25%. In 7% treatment was deemed to have failed. Forty-seven of 60 patients received one course of therapy, 8 received 2 courses, and 5 required 3 courses. An initial dose of 5 mg/kg per day oral prednisone therapy was more effective than 3 mg/kg per day. Side effects were not serious and resolved after discontinuation of therapy.
CONCLUSIONS: High oral doses of corticosteroids (5 mg/kg per day prednisone) provide an effective, rapid, and safe modality of treatment of hemangiomas of infants. We recommend that treatment continue for 6 to 8 weeks, and in more severe cases for as long as 12 weeks.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8551406     DOI: 10.1016/s0022-3476(96)70446-8

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  21 in total

Review 1.  Corticosteroid treatment of periorbital haemangioma of infancy: a review of the evidence.

Authors:  T M Ranchod; I J Frieden; D R Fredrick
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

2.  Evaluating systemic prednisone therapy for proliferating haemangioma in infancy.

Authors:  Jochen Rössler; Goetz Wehl; Charlotte Marie Niemeyer
Journal:  Eur J Pediatr       Date:  2007-08-04       Impact factor: 3.183

3.  Obstructive lesions of the pediatric subglottis.

Authors:  Jonathan B Ida; J Lindhe Guarisco; Kimsey H Rodriguez; Ronald G Amedee
Journal:  Ochsner J       Date:  2008

4.  Kasabach-merritt syndrome arising from tufted angioma successfully treated with systemic corticosteroid.

Authors:  Taegyun Kim; Mi Ryung Roh; Soohyun Cho; Kee Yang Chung
Journal:  Ann Dermatol       Date:  2010-11-05       Impact factor: 1.444

5.  Sub-Tenon's Steroid Irrigation for Treatment of Intraorbital Capillary Hemangioma.

Authors:  P G Firat; S Doganay; S Bilak; A Alkan
Journal:  Interv Neuroradiol       Date:  2008-02-01       Impact factor: 1.610

6.  Imaging and percutaneous treatment of vascular anomalies.

Authors:  Sandeep Vaidya; Daniel Cooke; Matthew Kogut; Peter G Stratil; Mark A Bittles; Manrita Sidhu
Journal:  Semin Intervent Radiol       Date:  2008-09       Impact factor: 1.513

Review 7.  Management of infantile hemangiomas : current and potential pharmacotherapeutic approaches.

Authors:  Brittany G Craiglow; Richard J Antaya
Journal:  Paediatr Drugs       Date:  2013-04       Impact factor: 3.022

8.  The steroid benefit in treating complicated haemangioma.

Authors:  Kamal H Saleh
Journal:  Indian J Plast Surg       Date:  2009-07

Review 9.  The changing face of complicated infantile hemangioma treatment.

Authors:  Deanna Menapace; Mario Mitkov; Richard Towbin; Marcia Hogeling
Journal:  Pediatr Radiol       Date:  2016-07-23

10.  Sclerotherapy using 1% sodium tetradecyl sulfate to treat a vascular malformation: a report of two cases.

Authors:  Hong-Gi Min; Su-Gwan Kim; Ji-Su Oh; Jae-Seek You
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2015-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.